Suppression of post-ischemic-induced Fos protein expression by an antisense oligonucleotide to c-fos mRNA leads to increased tissue damage

Brain Research

Volumn 832, Issue 1-2, 1999, Pages 112-117

  Zhang, Yi ^a   Widmayer, Marsha A ^a,b   Zhang, Benxiao ^a,b   Cui, Jian Kun ^a   Baskin, David S ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Antisense oligonucleotide; c fos; Cerebral infarction; Cerebral ischemia; Immediate early gene

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; MESSENGER RNA; NEUROTROPHIN; TRANSCRIPTION FACTOR AP 1; TRIPHENYLTETRAZOLIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY OCCLUSION; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; GENE ACTIVATION; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE CEREBRAL ARTERY; NERVE INJURY; NEUROPROTECTION; NONHUMAN; ONCOGENE C FOS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; CEREBRAL INFARCTION; DEPRESSION, CHEMICAL; IMMUNOHISTOCHEMISTRY; ISCHEMIC ATTACK, TRANSIENT; MALE; OLIGONUCLEOTIDES, ANTISENSE; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, LONG-EVANS; RNA, MESSENGER;

EID: 0033583935     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)01459-6     Document Type: Article

References (59)

1. Abe K., Tanzi R.E., Kogure K. Induction of HSP70 and mRNA after transient ischemia in gerbil brain. Neurosci. Lett. 125:1991;66-171.
2. Akins P.T., Liu P.K., Hsu C.Y. Immediate early gene expression in response to cerebral ischemia: friend or foe? Stroke. 27:1996;1682-1687.
3. An G., Lin T.N., Liu J.S.et al. Expression of c-fos and c-jun family genes after focal cerebral ischemia. Ann. Neurol. 33:1993;457-464.
4. Angel P., Allegretto E.A., Okino S.T.et al. Oncogene jun encodes a sequence-specific trans-activator similar to AP-1. Nature. 332:1988;166-171.
5. Bederson J.B., Pitts L.H. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke. 17:1986;472-476.
6. Bennett C.F., Chiang M.Y., Chan H.et al. Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides. Biochem. Pharmacol. 41:1992;1023-1033.
7. Bohmann D., Bos T.J., Admon A.et al. Human protooncogene c-jun encodes a DNA binding protein with structural and functional properties of transcription factor AP-1. Science. 238:1988;1386-1392.
8. Chiang M.Y., Chan H., Zounes M.et al. Antisense oligonucleotides inhibit intercellular adhesion molecule 1 expression by two distinct mechanisms. J. Biol. Chem. 266:1991;18162-18171.
9. Chiasson B.J., Hong M.G.L., Robertson H.A. Intra-amygdala infusin of an end-capped antisense oligonucleotide to c-fos accelerates amygdala kindling. Mol. Brain Res. 57:1998;248-256.
10. Chiasson B.J., Hooper M.L., Murphy P.R., Robertson H.A. Antisense oligonucleotide eliminates in vivo expression of c-fos in mammalian brain. Eur. J. Pharmacol. 227:1992;451-453.
11. Chiu R., Boyle W.J., Meek J.et al. The c-Fos protein interacts with c-Jun/AP-1 to stimulate transcription of AP-1 responsive genes. Cell. 54:1988;541-552.
12. Collaco-Moraces Y., Aspey B.S., de Belleroche J.S., Harrison M.J. Focal ischemia causes an extensive induction of immediate early genes that are sensitive to MK-801. Stroke. 25:1994;1855-1861.
13. Colotta F., Polentarutti N., Sironi M., Mantovani A. Expression and involvement of c-fos and c-jun protooncogenes in programmed cell death induced by growth factor deprivation in lymphoid cell lines. J. Biol. Chem. 267:1992;18278-18283.
14. Combs D.J., Dempsey R.J., Donaldson D., Kindy M.S. Hyperglycemia suppresses c-fos mRNA expression following transient cerebral ischemia in gerbils. J. Cereb. Blood Flow Metab. 12:1992;169-172.
15. Cui J.K., Hsu C.Y., Liu P.K. Suppression of post-ischemic hippocampal NGF expression by a c-fos antisense oligodeoxynucleotide. J. Neurosci. 19:1999;1335-1344.
16. Curran T., Abate C., Cohen D.R.et al. Inducible protooncogene transcription factors: third messengers in the brain? Cold Spring Harbor Symp. Quant. Biol. 150:1990;225-234.
17. Dash P., Lotan M., Knapp M.et al. Selective elimination of mRNAs in vivo: complementary oligodeoxynucleotides promote RNA degradation by an Rnase H-like activity. Proc. Natl. Acad. Sci. 84:1987;7896-7900.
18. H. Davson, M.B. Segal, Physiology of the CSF and Blood-Brain Barriers, Vol. 18, CRC Press, Boca Raton, FL, 1996.
19. Dempsey R.J., Carney J.M., Kindy M.S. Modulation of ornithine decarboxylase mRNA following transient ischemia in the gerbil brain. J. Cereb. Blood Flow Metab. 11:1991;979-985.
20. Edwards S.A., Rundell A.Y.K., Adamsom E.D. Expression of c-fos antisense RNA inhibits the differentiation of F9 cells to parietal endoderm. Dev. Biol. 129:1988;91-102.
21. Franza B.R., Rauscher F.J., Josephs S.F., Curran T. The Fos complex and Fos-related antigens recognize sequence elements that contain AP-1 binding sites. Science. 239:1988;1150-1153.
22. Goldgaber D., Harris H.W., Hla T.et al. Interleukin 1 regulates synthesis of amyloid b-protein precursor mRNA in human endothelial cells. Proc. Natl. Acad. Sci. 86:1989;7606-7610.
23. Gunn A.J., Dragunow M., Faull R.L., Gluckman P.D. Effects of hypoxia-ischemia and seizures on neuronal and glial-like c-fos protein levels in the infarct rat. Brain Res. 531:1990;105-116.
24. Hasanaga K., Sagar S.M., Sharp F.R. N-Methyl-D-aspartate antagonists block Fos-like protein expression induced via multiple signaling pathways in cultured cortical neurons. J. Neurochem. 58:1992;1836-1844.
25. Hengerer B., Lindholm D., Heumann R.et al. Lesion-induced increase in nerve growth factor mRNA is mediated by c-fos. Proc. Natl. Acad. Sci. 87:1990;3899-3903.
26. Holt C.E., Garlick N., Cornel E. Lipofection of cDNA in the embryonic vertebrate central nervous system. Neuron. 4:1990;203-214.
27. Islam N., Aftabuddin M., Moriwaki A., Hori Y. Induction of N-methyl-D-aspartate receptor mediated c-fos protein in the rat brain by incomplete ischemia. Ind. J. Med. Res. 100:1994;281-288.
28. Jacewicz M., Kiessling M., Pulsinelli W.A. Selective gene expression in focal cerebral ischemia. J. Cereb. Blood Flow Metab. 6:1986;263-272.
29. Kerr L.D., Holt J.T., Matrisian L.M. Growth factors regulate transin gene expression by c-fos-dependent and c-fos-independent pathways. Science. 242:1988;1424-1427.
30. Kindy M.S., Carney J.P., Dempsey R.J., Carney J.M. Ischemic induction of protooncogene expression in gerbil brain. J. Mol. Neurosci. 2:1991;217-228.
31. Kinouchi H., Sharp F.R., Chan P.H.et al. Induction of c-fos, junB, c-jun, and hsp70 mRNA in cortex, thalamus, basal ganglia, and hippocampus following middle cerebral artery occlusion. J. Cereb. Blood Flow Metab. 14:1994;808-817.
32. Levi B.Z., Kasik J.W., Ozato K. c-fos Antisense RNA blocks expression of c-fos gene in F9 embryonal carcinoma cells. Cell Differ. Dev. 25:1988;95-101. Suppl.
33. Levi B.Z., Ozato K. Constitutive expression of c-fos antisense RNA blocks c-fos gene induction by interferon and by phorbol ester and reduces c-myc expression in F9 embryonal carcinoma cells. Genes Dev. 2:1988;554-566.
34. Liebhaber S.A., Cash F.E., Shakin S.H. Translationally associated helix-destablizing activity in rabbit reticulocyte lysate. J. Biol. Chem. 259:1984;5597-15602.
35. Lindvall O., Ernfors P., Bengzon J.et al. Differential regulation of mRNAs for nerve growth factor, brain-derived neurotrophic factor, and neurotrophin 3 in the adult rat brain following cerebral ischemia and hypoglycemic coma. Proc. Natl. Acad. Sci. USA. 89:1992;648-652.
36. Liu H.M., Chen H.H. C-fos protein expression and ischemic changes in neurons vulnerable to ischemia/hypoxia, correlated with basic fibroblast growth factor immunoreactivity. J. Neuropathol. Exp. Neurol. 53:1994;598-605.
37. Liu P.K., Salminen A., He Y.Y.et al. Suppression of ischemia-induced expression and AP-1 activity by an antisense oligodeoxynucleotide to c-fos mRNA. Ann. Neurol. 36:1994;566-576.
38. Loke S.L., Stein C., Zhang X.H.et al. Characterization of oligonucleotide transport into living cells. Proc. Natl. Acad. Sci. USA. 86:1989;3474-3478.
39. Macgregor P.F., Abate C., Curran T. Direct cloning of leucine zipper proteins: Jun binds cooperatively to the CRE with CRE-BP1. Oncogene. 5:1990;451-458.
40. Malone R.W., Felgner P.L., Verma I.M. Cationic liposome-mediated RNA transfection. Proc. Natl. Acad. Sci. USA. 86:1989;6077-6081.
41. Menzies S.A., Hoff J.T., Betz A.L. Middle cerebral artery occlusion in rats: a neurological and pathological evaluation of a reproducible model. Neurosurgery. 31:1992;100-106.
42. Mercola D., Rundell A., Westwick J., Edwards S.A. Antisense RNA to the c-fos gene: restoration of density-dependent growth arrest in a transformed cell line. Biochem. Biophys. Res. Commun. 147:1987;288-294.
43. Merlio J.-P., Ernfors P., Kokaia Z.et al. Increased production of the TrkB protein tyrosine kinase receptor after brain insults. Neuron. 10:1993;151-164.
44. Mobley W.C., Neve R.L., Prusiner S.B., McKinley M.P. Nerve growth factor increases mRNA levels for the prion protein and the b-amyloid protein precursor in developing hamster brain. Proc. Natl. Acad. Sci. USA. 85:1988;9811-9815.
45. Nishikura K., Murray H.M. Antisense RNA of protooncogene c-fos blocks renewed growth of quiescent 3T3 cells. Mol. Cell Biol. 7:1987;637-649.
46. Nowak T.S. Jr. Localization of 70 kDa stress protein mRNA induction in gerbil brain after ischemia. J. Cereb. Blood Flow Metab. 11:1991;432-439.
47. Rocha L., Kaufman D.L. In vivo administration of c-Fos antisense oligonucleotides accelerates amygdala kindling. Neurosci. Lett. 241:1998;111-114.
48. Scanlon K.J., Jiao L., Funato T.et al. Ribozyme-mediated cleavage of c-fos mRNA reduces gene expression of DNA synthesis enzymes and metallothionein. Proc. Natl. Acad. Sci. USA. 88:1991;10591-10595.
49. Schönthal A., Herrlich P., Rahmsdorf H.J., Ponta H. Requirement for fos gene expression in the transcriptional activation of collagenase by other oncogenes and phorbol esters. Cell. 54:1988;325-334.
50. Sharp F.R., Lowenstein D., Simon R., Hisanaga K. Heat shock protein hsp72 induction in cortical striatal astrocytes and neurons following infarction. J. Cereb. Blood Flow Metab. 11:1991;621-627.
51. Sharp J.W., Sagar S.M., Hisanaga K.et al. The NMDA receptor mediates cortical induction of fos and fos-related antigens following cortical injury. Exp. Neurol. 109:1991;323-332.
52. Shimazu M., Mizushima H., Sasaki K.et al. Expression of c-fos in the rat cerebral cortex after focal ischemia and reperfusion. Brain Res. Bull. 33:1994;689-697.
53. Turner R., Tjian R. Leucine repeats and adjacent DNA bind domain mediate the formation of functional cFos-cJun heterodimers. Science. 243:1989;1689-1694.
54. Uemura Y., Kowall N.W., Moskowitz M.A. Focal ischemia in rats causes time-dependent expression of c-fos protein immunoreactivity in widespread regions of ipsilateral cortex. Brain Res. 552:1991;99-105.
55. Vass K., Welck W.J., Nowak T.S. Jr. Localization of 70-kDa stress protein induction in gerbil brain after ischemia. Acta Neuropathol. 77:1988;128-132.
56. Wahlestedt C., Golanov E., Yamamoto S.et al. Antisense oligonucleotides to NMDA-1 receptor channel protect cortical neurons from excitotoxicity and reduce focal ischemic infarctions. Nature. 363:1993;260-263.
57. Wang X., Yue T.-L., Young P.R.et al. Expression of interleukin-6, c-fos, and zif268 mRNAs in rat ischemic cortex. J. Cereb. Blood Flow Metab. 15:1995;166-171.
58. Welsh F.A., Moyer D.J., Harris V.A. Regional expression of heat shock protein-70 mRNA and c-fos mRNA following focal ischemia in rat brain. J. Cereb. Blood Flow Metab. 12:1992;204-212.
59. Yaida Y., Nowak T.S. Jr. Distribution of phosphodiester and phosphorothioate oligonucleotides in rat brain after intraventricular and intrahippocampal administration determined by in situ hybridization. Regul. Peptides. 59:1995;193-199.